advertisement
Abstract #15964 Published in IGR 2-3
Target intraocular pressure in glaucoma management
Realini T; Fechtner RDOphthalmology Clinics of North America 2000; 13: 407-415
All approved medical treatments for glaucoma have a common effect: they lower IOP. Although the relationship between IOP and glaucoma has been subject to re-examination, there is a large body of evidence that supports the concept of a pressure-related component of damage in some, if not all, patients with glaucoma. There is no available test to determine in advance who has this pressure-related component and might benefit from IOP-lowering treatment. Although one can validly question the basis for setting a particular target IOP, there is no basis for abandoning IOP lowering as a legitimate treatment strategy for eyes with glaucoma. The four-step approach outlined here will help us to maintain a rational approach to therapy. As studies, such as the OHTS and EMGTS, report their findings, there will be additional information on which to base clinical decisions. At present, physicians must balance the potential benefits with the burdens of therapy and accept that important questions remain to be answered.
Dr. R.D. Fechtner, Department of Ophthalmology, New Jersey Medical School, University of Medicine and Dentistry, 90 Bergen Street, Newark, NJ 07103, USA
Classification:
11.1 General management, indication (Part of: 11 Medical treatment)
